AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and six months ended

AURORA CANNABIS INC.

Condensed Consolidated

Interim Financial Statements (Unaudited)

For the three and six months

ended December 31, 2022 and 2021 (in Canadian Dollars)

The accompanying notes are an integral part of these Condensed

Consolidated Interim Financial Statements.

The accompanying notes are an integral part of these Condensed

Consolidated Interim Financial Statements.

The accompanying notes are an integral part of these Condensed

Consolidated Interim Financial Statements.

The accompanying notes are an integral part of these Condensed

Consolidated Interim Financial Statements.

(1) Included in share-based compensation is nil

relating to milestone payments for the three and six months ended December 31, 2022 (three and six months ended December 31, 2021 -

$0.5 and $0.5 million).

The accompanying notes are an integral part of these Condensed

Consolidated Interim Financial Statements.

Supplemental cash flow information (Note 20)

The accompanying notes are an integral part of these Condensed

Consolidated Interim Financial Statements.

Aurora Cannabis Inc. (the "Company"

or "Aurora") was incorporated under the Business Corporations Act (British Columbia) on December 21, 2006 as Milk Capital

Corp. Effective October 2, 2014, the Company changed its name to Aurora Cannabis Inc. The Company's shares are listed on the Nasdaq

Global Select Market ("Nasdaq") and the Toronto Stock Exchange ("TSX") under the trading symbol "ACB",

and on the Frankfurt Stock Exchange ("FSE") under the trading symbol "21P1".

The Company's head office

and principal address is 500 - 10355 Jasper Avenue, Edmonton, Alberta, Canada, T5J 1Y6. The Company's registered and records office

address is Suite 1700, 666 Burrard Street , Vancouver, British Columbia, Canada, V6C 2X8.

The Company's principal strategic

business lines are focused on the production, distribution and sale of cannabis related products in Canada and internationally. Aurora

currently conducts the following key business activities in the jurisdictions listed below:

On August 25, 2022, the Company

acquired a 50.1% controlling interest in Bevo Agtech Inc. ("Bevo"), the sole parent of Bevo Farms Ltd. in order to support

the Company's principal cannabis operations. Bevo is one of the largest suppliers of propagated vegetables and ornamental plants

Accounting Policies and Judgments

The condensed consolidated interim

financial statements of the Company have been prepared in accordance with International Financial Reporting Standards ("IFRS")

and International Accounting Standards 34, Interim Financial Reporting ("IAS 34") as issued by the International Accounting

Standards Board ("IASB"), and interpretations of the IFRS Interpretations Committee ("IFRIC"). Unless otherwise

noted, all amounts are presented in thousands of Canadian dollars, except share and per share data.

The Company has reclassified certain comparative balances to conform

with the current period's presentation.

The condensed consolidated interim

financial statements are presented in Canadian dollars and are prepared in accordance with the same accounting policies, critical estimates

and methods described in the Company's annual consolidated financial statements, except for the adoption of new accounting policies

(Note 2(c) and (d)). Given that certain information and footnote disclosures, which are included in the annual audited consolidated financial

statements, have been condensed or excluded in accordance with IAS 34, these condensed consolidated interim financial statements should

be read in conjunction with our annual audited consolidated financial statements as at and for the year ended June 30, 2022, including

the accompanying notes thereto.

The consolidated financial statements

include the financial results of the Company and its subsidiaries. Subsidiaries include entities which are wholly-owned as well as entities

over which Aurora has the authority or ability to exert power over the investee's financial and/or operating decisions (i.e. control),

which in turn may affect the Company's exposure or rights to the variable returns from the investee. The consolidated financial

statements include the operating results of acquired or disposed entities from the date control is obtained or the date control is lost,

respectively. All intercompany balances and transactions are eliminated upon consolidation.

The Company's principal subsidiaries during the three and

six months ended December 31, 2022 are as follows:

All shareholdings are of ordinary

shares or other equity. Other subsidiaries, while included in the consolidated financial statements, are not material and have not been

reflected in the table above.

Put Option Liability

The Company has entered into a

put option with certain non-controlling interest shareholders of Bevo such that the Company is required to purchase their shareholding

under certain conditions as of the exercise date. When accounting for options related to non-controlling interests, the Company applies

IFRS 10, Consolidated Financial Statements, and the terms of the contracts are analyzed to assess whether they provide the Company

or the non-controlling interest with access to the risks and rewards associated with the actual ownership of the shares. The Company has

elected the present-access method of accounting for non-controlling interests. As a result, the Company has recognized a financial liability

at the present value of the amount payable on exercise of the put option. Remeasurement adjustments are recorded in deficit.

of New Accounting Pronouncements

Amendments to IAS 41: Agriculture

As part of its 2018-2020 annual

improvements to IFRS standards process, the IASB issued amendments to IAS 41. The amendment removes the requirement for entities to exclude

taxation cash flows when measuring the fair value of a biological asset using a present value technique. This will ensure consistency

with the requirements in IFRS 13. The amendment is effective for annual reporting periods beginning on or after January 1, 2022. The Company

adopted the Amendments to IAS 41 effective July 1, 2022 which did not have a material impact to the Company's consolidated financial

Amendments to IFRS 9: Financial Instruments

As part of its 2018-2020 annual

improvements to IFRS standards process, the IASB issued amendments to IFRS 9. The amendment clarifies the fees that an entity includes

when assessing whether the terms of a new or modified financial liability are substantially different from the terms of the original financial

liability. These fees include only those paid or received between the borrower and the lender, including fees paid or received by either

the borrower or lender on the other's behalf. An entity applies the amendment to financial liabilities that are modified or exchanged

on or after the beginning of the annual reporting period in which the entity first applies the amendment. The amendment is effective for